The reliability and validity of outcome measures for atopic dermatitis in patients with pigmented skin: A grey area
- PMID: 28491979
- PMCID: PMC5418878
- DOI: 10.1016/j.ijwd.2015.05.002
The reliability and validity of outcome measures for atopic dermatitis in patients with pigmented skin: A grey area
Abstract
Background: Outcome measures for atopic dermatitis (AD) patients with pigmented skin have neither been developed nor validated.
Objective: To compare the reliability and validity of four common AD outcome measures in patients with various levels of skin darkness.
Method: The inter- and intra-rater reliability and construct validity of the EASI (Eczema Area and Severity Index), objective-SCORing Atopic Dermatitis (oSCORAD), Three Items Severity index (TIS) and Six Areas, Six Sites Atopic Dermatitis (SASSAD) were evaluated in 18 patients of various levels of skin darkness, using their full body photographs, by five trained clinicians.
Results: The inter-rater reliability intraclass coefficient (ICCs) and 95% confidence intervals were poor for highly pigmented patients: EASI -.054(-.200 to .657), oSCORAD -.089(-.206 to .598), TIS -.21(-.24 to .147), SASSAD -.071(-.200 to .631); fair for mildly pigmented patients: EASI .464(.140-.839), oSCORAD .588(.265-.89), TIS.524(.200-.865), SASSAD .41(.045-.775); and fair to good for non-pigmented patients: EASI .64(.330-.908), oSCORAD .586(.263-.889), TIS .403(.09-.809), SASSAD .667(.358-.916). Erythema likely contributed to the inter-rater variability. Construct validity had significant correlations across all measures in non-pigmented patients, but no correlations in highly pigmented patients.
Conclusion: AD outcome measures have poor reliability and validity in highly pigmented patients, with variations in erythema perception being a contributor.
Keywords: Atopic dermatitis; Outcome measures; Skin of color.
Similar articles
-
A pilot comparison study of four clinician-rated atopic dermatitis severity scales.Br J Dermatol. 2015 Aug;173(2):488-97. doi: 10.1111/bjd.13846. Epub 2015 Jul 1. Br J Dermatol. 2015. PMID: 25891151 Clinical Trial.
-
Assessment of Intra- and Inter-Rater Reliability of Three Methods for Measuring Atopic Dermatitis Severity: EASI, Objective SCORAD, and IGA.Dermatology. 2017;233(1):16-22. doi: 10.1159/000472711. Epub 2017 May 12. Dermatology. 2017. PMID: 28494438
-
A comparison study of clinician-rated atopic dermatitis outcome measures for intermediate- to dark-skinned patients.Br J Dermatol. 2017 Apr;176(4):985-992. doi: 10.1111/bjd.15271. Epub 2017 Mar 1. Br J Dermatol. 2017. PMID: 28012183 Clinical Trial.
-
Eczema Severity Scoring in Skin of Color: A Review of Current Best Practice and Need for Future Improvement.J Invest Dermatol. 2025 Apr;145(4):735-748. doi: 10.1016/j.jid.2025.02.001. Epub 2025 Feb 24. J Invest Dermatol. 2025. PMID: 39998455 Review.
-
Outcome measures of disease severity in atopic eczema.Arch Dermatol. 2000 Jun;136(6):763-9. doi: 10.1001/archderm.136.6.763. Arch Dermatol. 2000. PMID: 10871941 Review.
Cited by
-
Dupilumab Improves Skin Barrier Function in Adults with Atopic Dermatitis: A Prospective Observational Study.J Clin Med. 2022 Jun 10;11(12):3341. doi: 10.3390/jcm11123341. J Clin Med. 2022. PMID: 35743415 Free PMC article.
-
Remote severity assessment in atopic dermatitis: Validity and reliability of the remote Eczema Area and Severity Index and Self-Administered Eczema Area and Severity Index.JAAD Int. 2023 Aug 28;13:184-191. doi: 10.1016/j.jdin.2023.07.019. eCollection 2023 Dec. JAAD Int. 2023. PMID: 38025299 Free PMC article.
-
The erythema Q-score, an imaging biomarker for redness in skin inflammation.Exp Dermatol. 2021 Mar;30(3):377-383. doi: 10.1111/exd.14224. Epub 2020 Nov 30. Exp Dermatol. 2021. PMID: 33113259 Free PMC article.
-
Racial disparities in dermatology.Arch Dermatol Res. 2023 Jul;315(5):1215-1223. doi: 10.1007/s00403-022-02507-z. Epub 2022 Dec 12. Arch Dermatol Res. 2023. PMID: 36508020 Free PMC article.
-
Solving the health disparity of eczema assessment: A role for skin tape soluble protein?J Allergy Clin Immunol Glob. 2023 Oct 17;3(1):100180. doi: 10.1016/j.jacig.2023.100180. eCollection 2024 Feb. J Allergy Clin Immunol Glob. 2023. PMID: 38026505 Free PMC article.
References
-
- Ahmad Fadzil M.H., Ihtatho D., Mohd Affandi A., Hussein S.H. Objective assessment of psoriasis erythema for PASI scoring. J Med Eng Technol. 2009;33(7):516–524. - PubMed
-
- Ben-Gashir M.A., Hay R.J. Reliance on erythema scores may mask severe atopic dermatitis in black children compared with their white counterparts. Br J Dermatol. 2002;147(5):920–925. - PubMed
-
- Berardesca E., Maibach H. Ethnic skin: overview of structure and function. J Am Acad Dermatol. 2003;48(Suppl. 6):S139–S142. - PubMed
-
- Berth-Jones J. Six area, six sign atopic dermatitis (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis. Br J Dermatol. 1996;135(Suppl. 48):25–30. - PubMed
-
- Bhattacharya T., Silverberg J.I. Efficacy of systemic treatments for atopic dermatitis in racial and ethnic minorities in the United States. JAMA Dermatol. 2014;150(11):1232–1234. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases